תאריך רישום: December 6, 2007

מסלול הגשה: תכשיר גנרי

יצרן: RECKITT BENCKISER HEALTHCARE (UK) LIMITED

בעל רישום: RECKITT BENCKISER (NEAR EAST) LTD

M01AE01 :ATC Code

4.1 Therapeutic indications For the reduction of fever and relief of mild to moderate pain. For infants and children aged 3 months to 12 years (i.e. weighing about 40 kg).

תאריך רישום: October 27, 2016

מסלול הגשה: מולקולה חדשה

יצרן: ASPEN BAD OLDESLOE GMBH, GERMANY

בעל רישום: PADAGIS ISRAEL AGENCIES LTD, ISRAEL

G03CA04 :ATC Code

4.1 Therapeutic indications For the treatment of vulvo-vaginal complaints related to estrogen deficiency.

תאריך רישום: March 28, 1993

מסלול הגשה: מולקולה חדשה

יצרן: CENEXI , FRANCE

בעל רישום: PADAGIS ISRAEL AGENCIES LTD, ISRAEL

N01BB01 :ATC Code

4.1 Therapeutic indications Spinal anaesthesia for surgery.

תאריך רישום: March 28, 1993

מסלול הגשה: מולקולה חדשה

יצרן: ASPEN BAD OLDESLOE GMBH, GERMANY

בעל רישום: PADAGIS ISRAEL AGENCIES LTD, ISRAEL

D04AB01 :ATC Code

4.1. Therapeutic indications Surface anaesthesia in dental practice otorhinolaryngology, obstetric and anaesthesiology.

תאריך רישום: June 2, 2018

מסלול הגשה: ביו סימילאר

יצרן: LABORATORIOS FARMACEUTICOS ROVI, S.A.

בעל רישום: TZAMAL BIO-PHARMA LTD

B01AB05 :ATC Code

4.1 Therapeutic indications This medicinal product is indicated in adults for: • Prophylaxis of venous thromboembolic disease in moderate and high risk surgical patients, in particular those undergoing orthopaedic or general surgery including cancer surgery. • Prophylaxis of venous thromboembolic disease in medical patients with an acute illness (such as acute heart failure, respiratory insufficiency, severe infections or rheumatic diseases) and reduced mobility at increased risk of venous thromboembolism. • Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), excluding PE likely to require thrombolytic therapy or surgery. • Prevention of thrombus formation in extra corporeal circulation during haemodialysis. • Acute coronary syndrome: - Treatment of unstable angina and Non ST-segment elevation myocardial infarction (NSTEMI), in combination with oral acetylsalicylic acid. - Treatment of acute ST-segment elevation myocardial infarction (STEMI) including patients to be managed medically or with subsequent percutaneous coronary intervention (PCI).

תאריך רישום: October 3, 2021

מסלול הגשה: חוזק חדש

יצרן: NOVARTIS PHARMA SAS, FRANCE

בעל רישום: NOVARTIS ISRAEL LTD

R03DX05 :ATC Code